Dermata Therapeutics, Inc. (DRMA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $7.52M | +137.9% |
| 2024 | $3.16M | — |
| 2022 | $6.24M | -42.2% |
| 2021 | $10.80M | +1936.0% |
| 2020 | $530.4K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $7.52M | +137.9% |
| 2024 | $3.16M | — |
| 2022 | $6.24M | -42.2% |
| 2021 | $10.80M | +1936.0% |
| 2020 | $530.4K | — |